Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BGM GroupBGM +6.15%36 Quick Ratio is 0.76 as of Sep. 2025, which is 45% below its 10-year median of 1.39. GuruFocus rates BGM with a GF Score™ of 36/100 and a GF Value™ of $0.25 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 995 Drug Manufacturers companies, BGM Group ranks worse than 77.89% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. BGM Group's quick ratio for the quarter that ended in Sep. 2025 was 0.76.
BGM Group has a quick ratio of 0.76. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for BGM Group's Quick Ratio or its related term are showing as below:
BGM'
s Quick Ratio Range Over the Past 10 Years
Min: 0.51 Med: 1.39 Max: 4.43
Current: 0.76
During the past 9 years, BGM Group's highest Quick Ratio was 4.43. The lowest was 0.51. And the median was 1.39.
BGM's Quick Ratio is ranked worse than 77.89% of 995
companies
in the Drug Manufacturers industry
Industry Median: 1.42
vs BGM: 0.76
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
BGM Group Quick Ratio Related Terms
BGM Group Quick Ratio Historical Data
* Premium members only.
The historical data trend for BGM Group's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, BGM Group's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BGM Group Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BGM Group's Quick Ratio distribution charts can be found below:
* The bar in red indicates where BGM Group's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
BGM Group's Quick Ratio for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BGM Group (BGM) has a Quick Ratio of 0.76 as of Sep. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on BGM Group and its competitors. This is 45% below median its historical median of 1.39. Over the past decade, BGM Group's Quick Ratio has ranged from 0.51 to 4.43. According to the industry distribution chart, BGM Group ranks #775 out of 995 companies in the Drug Manufacturers industry, placing it in the top 77.9%.
Is BGM Group's Quick Ratio too high?
BGM Group's current Quick Ratio of 0.76 is 45% below median its 10-year median of 1.39. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 4.43. The Drug Manufacturers industry median Quick Ratio is 1.42. BGM Group's value of 0.76 is 46.5% below this industry median. Based on the distribution chart, BGM Group ranks #775 out of 995 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, BGM Group has a GF Score™ of 36/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BGM Group's Quick Ratio compare to CPIX and ADCT?
According to the Drug Manufacturers industry distribution chart, BGM Group ranks #775 out of 995 companies for Quick Ratio. This places BGM Group in the lower half of its industry. The industry median Quick Ratio is 1.42. BGM Group's value of 0.76 is 46.5% below this benchmark. Historically, BGM Group's own Quick Ratio has ranged from 0.51 to 4.43 over the past decade. While the company's 10-year median is 1.39 vs. the industry median of 1.42, BGM Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.42, based on 995 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BGM Group's current Quick Ratio of 0.76 is 46.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on BGM Group and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BGM Group's current Quick Ratio is 0.76, which is 45% below median its own 10-year median of 1.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BGM Group stock overvalued right now?
Based on GuruFocus' analysis, BGM Group (BGM) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.25, compared to a current price of $0.29 — trading 16.7% above its estimated fair value. The current Quick Ratio is 0.76, which is 45% below median its 10-year median of 1.39 and 46.5% below the Drug Manufacturers industry median of 1.42. BGM Group's overall GF Score™ is 36/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For BGM Group (BGM), the current Quick Ratio is 0.76 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BGM Group (BGM) Overvalued in 2026?
Based on GuruFocus' analysis, BGM Group stock appears to be overvalued.
The current stock price of $0.29 is trading 16.7% above its estimated GF Value™ of $0.25.
GuruFocus considers BGM Group to be Modestly Overvalued.
Key valuation signals for BGM:
Quick Ratio: 0.76 (45% below median its 10-year median of 1.39)
GF Value™: $0.25 vs. price of $0.29 (16.7% above fair value)
Industry Position: 46.5% below the Drug Manufacturers median (#775 of 995)
No single metric tells the full story. See the BGM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
36GF Score
Get the complete analysis for BGM
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BGM has been successfully added to your 
